Defense and space stocks rally, but Trump’s buyback-dividend squeeze is the next test

Defense and space stocks rally, but Trump’s buyback-dividend squeeze is the next test

New York, Feb 7, 2026, 12:51 EST — Market closed.

  • Space and defense stocks climbed Friday, with sector ETFs and major U.S. primes leading the way.
  • Focus swings to a Pentagon list that might restrict buybacks and dividends for contractors missing performance targets.
  • Traders want to see just how broadly this net gets thrown, and if the policy actually holds up.

Space and defense names trading in the U.S. finished in the green Friday. The market’s focus, though, has shifted—earnings aren’t the spark this time, nor is fresh demand for missiles. Instead, investors are eyeing an upcoming Pentagon list that threatens to restrict buybacks and dividends for contractors failing to meet delivery targets.

Why it matters now: Buybacks and dividends have long underpinned the bull case for legacy defense stocks, offering steady payouts to shareholders. But with Washington signaling a tougher stance, what’s usually a reliable income play could quickly shift into headline risk territory—at least for the next few sessions.

The iShares U.S. Aerospace & Defense ETF climbed 3.5% Friday. SPDR S&P Aerospace & Defense ETF posted a stronger move, up 4.8%, while Invesco Aerospace & Defense ETF ticked 3.3% higher. Lockheed Martin finished 2.4% ahead; Northrop Grumman put on 1.8%, and RTX added 1.4%. General Dynamics pushed 2.3% higher, L3Harris closed up 2.1%. GE Aerospace surged 4.7%. On the space side, Planet Labs and AST SpaceMobile each rallied roughly 9%. Iridium picked up about 4.5%.

The Pentagon’s working on a list of defense contractors that might soon see curbs on share buybacks and dividends, following President Donald Trump’s January 7 executive order. The move links future payouts to how well companies stick to contract terms and delivery deadlines. Pentagon spokesperson Sean Parnell said the review is taking longer than expected and signaled the department won’t hesitate to enforce the rules if progress lags. Once named, firms would get 15 days to turn in remediation plans signed off by their boards. The order also tells the SEC to weigh restrictions on some repurchase-related protections.

Some investors and financial advisers warn the policy could squeeze shareholder returns and muddy executive incentives. David Sowerby, managing director at Ancora Advisors, described the move as “three-quarters of a step back” in capital allocation, criticizing what he sees as micromanagement. Charles Lieberman, chief investment officer at Advisors Capital Management, pushed back as well, saying “cash flow is not a constraint” and that capacity depends on demand, not payouts. Consultant Richard Aboulafia added that tighter dividends might turn sentiment in favor of “the new guys.” RTX CEO Christopher Calio, meanwhile, maintains the company isn’t wavering on its dividend. Reuters

Lockheed’s board on Friday cleared a $3.45 per-share dividend for the first quarter of 2026, set for payment on March 27 to holders registered by March 2.

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Constellation Energy

NASDAQ: CEG 95 / 100
#2 BUY

AerCap

NYSE: AER 93 / 100
#3 BUY

Walt Disney

NYSE: DIS 92 / 100
#4 ACCUMULATE

AIG

NYSE: AIG 90 / 100
#5 BUY ON PULLBACK

Cheniere Energy

NYSE: LNG 88 / 100
View full portfolio
Editorial model selection. Not personalised advice.
Dow Jones breaks 50,000 for the first time — here’s what Wall Street watches next
Previous Story

Dow Jones breaks 50,000 for the first time — here’s what Wall Street watches next

Healthcare stocks in focus: Molina shock, FDA “copycat” warning and XLV set up Monday’s trade
Next Story

Healthcare stocks in focus: Molina shock, FDA “copycat” warning and XLV set up Monday’s trade